AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vidoglipt M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

3D Healthcare

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vidoglipt M 500mg/50mg Tablet

Combiflor 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combiflor may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control is crucial for preventing future health issues. Adherence to the prescribed diet and exercise regimen is vital. Lifestyle modifications are integral to diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect when used with insulin or sulfonylureas; patients should be aware of its symptoms and management. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Drug interactions are possible; disclose all current medications to ensure safety. Alcohol should be avoided due to its hypoglycemic effect. Kidney function and blood glucose will be monitored regularly throughout treatment.

Uses of Vidoglipt M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Vidoglipt M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vidoglipt M 500mg/50mg tablet should be administered with a meal.

Common Side effects of Vidoglipt M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vidoglipt M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 500mg/50mg Vidoglipt M tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Vidoglipt M 500mg/50mg Tablet works:

The dual-action tablet, Vidoglipt M 500mg/50mg, combines two distinct anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vidoglipt M 500mg/50mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vidoglipt M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vidoglipt M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vidoglipt M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverUNSAFE

Use of Vidoglipt M 500mg/50mg tablets in patients with liver conditions is likely inadvisable and should be avoided. Medical advice is recommended.

What if you forget to take Vidoglipt M 500mg/50mg Tablet :

Should you forget a Vidoglipt M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vidoglipt M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Vidoglipt M 500mg/50mg Tablet

Vidoglipt M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can occur if insufficient calories are consumed. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vidogliptin M 500mg/50mg tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Never take other medications without first talking to your doctor.
Vidoglipt M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vidoglipt M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vidoglipt M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this risk is heightened in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged use of Vidoglipt M 500mg/50mg Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vidoglipt M 500mg/50mg tablets are safe when used as directed by your doctor. However, even with correct usage, common side effects may include nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar, especially if used with insulin or sulphonylurea). Report any persistent side effects to your physician.
Vidoglipt M 500mg/50mg Ta...
111
MRP 129
13% off